Cirsium Biosciences: Valuation, Funding & Investors
Cirsium Biosciences is developing a plant-based manufacturing platform designed to significantly reduce the production time and cost of viral vector-based gene therapies. Their innovative approach aims to establish a scalable and cost-effective process for producing viral vectors, achieving up to an 80% reduction in manufacturing lead times for AAV gene therapies. This platform addresses the growing demand for gene therapies and aims to alleviate potential shortages of specific vector types.
Leadership & Board
- Current Number of Employees
- 30
- Current LinkedIn Followers
- 4,341
Latest Estimated Valuation
- Total Amount Raised
- $61M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $61M
- Latest Funding Round
- Investment
Employee Trend
Cirsium Biosciences had 30 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Cirsium Biosciences had 4,341 followers as of November 9, 2026. The number of followers increased by 5 (0.12%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Investment | $61.00M | ― |
Similar Companies
A snapshot of private companies similar to Cirsium Biosciences, helping you discover and navigate related company profiles.
Related News and Analysis
